Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

1.83
-0.0600-3.17%
Post-market: 1.910.0800+4.37%19:48 EDT
Volume:570.09K
Turnover:1.06M
Market Cap:258.25M
PE:-4.00
High:1.89
Open:1.89
Low:1.83
Close:1.89
52wk High:3.10
52wk Low:1.33
Shares:141.12M
Float Shares:101.18M
Volume Ratio:0.92
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4578
EPS(LYR):-0.4702
ROE:-57.40%
ROA:-19.76%
PB:2.83
PE(LYR):-3.89

Loading ...

ProQR Q1 FY26 net loss widens to €13.38 million; revenue drops to €2.03 million

Reuters
·
May 12

BRIEF-ProQR Therapeutics Q1 EPS EUR -0.13

Reuters
·
May 12

ProQR Therapeutics Q1 Revenue EUR 2.033 Million VS. Ibes Estimate EUR 5.25 Million

THOMSON REUTERS
·
May 12

ProQR Therapeutics Q1 Net Income EUR -13.383 Million

THOMSON REUTERS
·
May 12

ProQR Therapeutics Q1 Basic EPS EUR -0.13

THOMSON REUTERS
·
May 12

ProQR to present Axiomer RNA editing data at upcoming scientific conferences

Reuters
·
May 11

ProQR Therapeutics NV expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 04

ProQR Therapeutics announces annual shareholder meeting

Reuters
·
May 04

ProQR Announces Nomination of DR. Lykke Hinsch Gylvin to Its Board of Directors

THOMSON REUTERS
·
Apr 30

ProQR spotlights AX-0810 milestones at investor and analyst event

Reuters
·
Apr 09

BRIEF-Proqr Announces Partnership With Ginkgo Bioworks And Formation Of Ai Advisory Board

Reuters
·
Apr 08

ProQR partners with Ginkgo Bioworks to scale AI-enabled RNA editing discovery

Reuters
·
Apr 08

ProQR Announces Partnership With Ginkgo Bioworks and Formation of AI Advisory Board

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Expects First AI-Discovered Development Candidate to Enter Clinic in 2026

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Ginkgo Bioworks Makes Strategic Equity Investment in ProQR

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics to host virtual investor and analyst event; pipeline spotlight to include AX-0810 indication update

Reuters
·
Mar 25

ProQR Therapeutics’ Chief Scientific Officer Gerardus Johannes Platenburg files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Domenico Valerio Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

ProQR Therapeutics NV CFO Dennis Hom files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics director Alison Frances Lawton files Form 3 initial beneficial ownership statement

Reuters
·
Mar 19